UPDATE Wednesday, June 22, 2022, 2:50 p.m. EDT—CVS Health issued this statement: “We do not comment on specific PBM client contract terms. Our clients are sophisticated purchasers, and we work closely with them to customize a benefit design meeting their specific requirements. We support the 340B drug discount program and its role in helping vulnerable populations access critical medications.“
Hospitals and health centers say claims dating back to Jan. 1 have been reversed without notice or explanation this month for 340B-purchased drugs that CVS Specialty dispensed under contract pharmacy arrangements to participants in the Blue Cross and Blue Shield Federal Employee Program (FEP).
Hospitals and health centers say claims dating back to Jan. 1 have been reversed without notice or explanation this month for 340B-purchased drugs that CVS Specialty dispensed under contract pharmacy arrangements to participants in the Blue Cross and Blue Shield Federal Employee Program (FEP).
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
